Patents by Inventor Adrienne LI

Adrienne LI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ALK POLYPEPTIDES AND METHODS OF USE THEREOF
    Publication number: 20230302108
    Abstract: The invention features immunogenic compositions containing anaplastic lymphoma kinase (ALK) polypeptides and methods of use thereof. The immunogenic compositions and methods of the invention may be used to treat a disease associated with ALK in a subject, such as cancer (e.g., a solid tumor cancer or an ALK+ cancer).
    Type: Application
    Filed: February 28, 2023
    Publication date: September 28, 2023
    Inventors: Adrienne Li, Jackson Eby, Peter C. DeMuth
  • ALK polypeptides and methods of use thereof
    Patent number: 11623002
    Abstract: The invention features immunogenic compositions containing anaplastic lymphoma kinase (ALK) polypeptides and methods of use thereof. The immunogenic compositions and methods of the invention may be used to treat a disease associated with ALK in a subject, such as cancer (e.g., a solid tumor cancer or an ALK+ cancer).
    Type: Grant
    Filed: January 27, 2017
    Date of Patent: April 11, 2023
    Assignee: Elicio Therapeutics, Inc.
    Inventors: Adrienne Li, Jackson Eby, Peter C. Demuth
  • ALK POLYPEPTIDES AND METHODS OF USE THEREOF
    Publication number: 20200405834
    Abstract: The invention features immunogenic compositions containing anaplastic lymphoma kinase (ALK) polypeptides and methods of use thereof. The immunogenic compositions and methods of the invention may be used to treat a disease associated with ALK in a subject, such as cancer (e.g., a solid tumor cancer or an ALK+ cancer).
    Type: Application
    Filed: January 27, 2017
    Publication date: December 31, 2020
    Inventors: Adrienne LI, Jackson EBY, Peter C. DEMUTH
  • MULTILAMELLAR LIPID VESICLE COMPOSITIONS INCLUDING A CONJUGATED ANAPLASTIC LYMPHOMA KINASE (ALK) VARIANT AND USES THEREOF
    Publication number: 20180000906
    Abstract: The invention provides compositions including stabilized multilamellar lipid vesicles having crosslinked lipid bilayers (referred to herein as interbilayer-crosslinked multilamellar vesicles or ICMV) and including an ALK variant, pharmaceutical compositions containing vesicles (e.g., ICMV) including an ALK variant, and methods of treatment using such compositions. The invention provides compositions including stabilized multilamellar lipid vesicles with crosslinked lipid bilayers (e.g., an interbilayer-crosslinked multilamellar vesicle or ICMV) containing an Anaplastic lymphoma kinase (ALK) variant as an antigen that is associated with solid tumor cancers.
    Type: Application
    Filed: January 15, 2016
    Publication date: January 4, 2018
    Applicant: Vedantra Pharmaceuticals, Inc.
    Inventors: Adrienne LI, Jackson EBY, Peter C. DEMUTH
  • MULTILAMELLAR LIPID VESICLE COMPOSITIONS AND METHODS OF USE
    Publication number: 20170246288
    Abstract: The present invention provides novel and inventive drug delivery systems with higher loading capability, a capacity to sequester high tumors levels of both hydrophobic and hydrophilic agents simultaneously, and longer release profiles. Some aspects of these delivery systems include compositions including stabilized multilamellar lipid vesicles having crosslinked lipid bilayers (referred to herein as inter-bilayer-crosslinked multilamellar vesicles or ICMV) covalently conjugated to an agent (e.g., an antigen).
    Type: Application
    Filed: September 11, 2015
    Publication date: August 31, 2017
    Applicant: Vedantra Pharmaceuticals, Inc.
    Inventors: Adrienne LI, Jackson EBY, Peter C. DEMUTH